These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 24953043

  • 1. A computational prospect to aspirin side effects: aspirin and COX-1 interaction analysis based on non-synonymous SNPs.
    Marjan MN, Hamzeh MT, Rahman E, Sadeq V.
    Comput Biol Chem; 2014 Aug; 51():57-62. PubMed ID: 24953043
    [Abstract] [Full Text] [Related]

  • 2. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
    Vannini F, Chattopadhyay M, Kodela R, Rao PPN, Kashfi K.
    Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
    [Abstract] [Full Text] [Related]

  • 3. Mechanistic insights into cyclooxygenase irreversible inactivation by aspirin.
    Tosco P, Lazzarato L.
    ChemMedChem; 2009 Jun; 4(6):939-45. PubMed ID: 19301318
    [Abstract] [Full Text] [Related]

  • 4. COX Inhibition Profile and Molecular Docking Studies of Some 2-(Trimethoxyphenyl)-Thiazoles.
    Oniga SD, Pacureanu L, Stoica CI, Palage MD, Crăciun A, Rusu LR, Crisan EL, Araniciu C.
    Molecules; 2017 Sep 09; 22(9):. PubMed ID: 28891941
    [Abstract] [Full Text] [Related]

  • 5. High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs--pharmacological mechanisms and clinical relevance.
    Hohlfeld T, Saxena A, Schrör K.
    Thromb Haemost; 2013 May 09; 109(5):825-33. PubMed ID: 23238666
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
    Abdel-Aziz AA, ElTahir KE, Asiri YA.
    Eur J Med Chem; 2011 May 09; 46(5):1648-55. PubMed ID: 21388719
    [Abstract] [Full Text] [Related]

  • 7. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC, Kania J, Burnat G, Hahn EG.
    J Physiol Pharmacol; 2006 Dec 09; 57 Suppl 12():15-24. PubMed ID: 17244951
    [Abstract] [Full Text] [Related]

  • 8. Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release.
    Kowalski ML, Borowiec M, Kurowski M, Pawliczak R.
    Allergy; 2007 Jun 09; 62(6):628-34. PubMed ID: 17508966
    [Abstract] [Full Text] [Related]

  • 9. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
    Pawlik M, Pajdo R, Kwiecien S, Ptak-Belowska A, Sliwowski Z, Mazurkiewicz-Janik M, Konturek SJ, Pawlik WW, Brzozowski T.
    J Physiol Pharmacol; 2011 Feb 09; 62(1):75-86. PubMed ID: 21451212
    [Abstract] [Full Text] [Related]

  • 10. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients.
    Martín-García C, Hinojosa M, Berges P, Camacho E, García-Rodriguez R, Alfaya T.
    J Investig Allergol Clin Immunol; 2003 Feb 09; 13(1):20-5. PubMed ID: 12861847
    [Abstract] [Full Text] [Related]

  • 11. Aspirin and NSAID sensitivity.
    Stevenson DD.
    Immunol Allergy Clin North Am; 2004 Aug 09; 24(3):491-505, vii. PubMed ID: 15242723
    [Abstract] [Full Text] [Related]

  • 12. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk.
    Howard PA, Delafontaine P.
    J Am Coll Cardiol; 2004 Feb 18; 43(4):519-25. PubMed ID: 14975457
    [Abstract] [Full Text] [Related]

  • 13. Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity.
    Unsal-Tan O, Ozadali K, Piskin K, Balkan A.
    Eur J Med Chem; 2012 Nov 18; 57():59-64. PubMed ID: 23047224
    [Abstract] [Full Text] [Related]

  • 14. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
    Zambre AP, Ganure AL, Shinde DB, Kulkarni VM.
    J Chem Inf Model; 2007 Nov 18; 47(2):635-43. PubMed ID: 17256838
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A, Cavalcanti F, Miralles A, Bayón Y, Alonso A, Merlos M, García-Rafanell J, Forn J.
    Mol Pharmacol; 1999 Apr 18; 55(4):753-60. PubMed ID: 10101034
    [Abstract] [Full Text] [Related]

  • 16. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL.
    Mol Pharmacol; 1999 Apr 18; 55(4):625-31. PubMed ID: 10101019
    [No Abstract] [Full Text] [Related]

  • 17. Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.
    Lucido MJ, Orlando BJ, Vecchio AJ, Malkowski MG.
    Biochemistry; 2016 Mar 01; 55(8):1226-38. PubMed ID: 26859324
    [Abstract] [Full Text] [Related]

  • 18. Covalent modification of cyclooxygenase-2 (COX-2) by 2-acetoxyphenyl alkyl sulfides, a new class of selective COX-2 inactivators.
    Kalgutkar AS, Kozak KR, Crews BC, Hochgesang GP, Marnett LJ.
    J Med Chem; 1998 Nov 19; 41(24):4800-18. PubMed ID: 9822550
    [Abstract] [Full Text] [Related]

  • 19. Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets.
    Saxena A, Balaramnavar VM, Hohlfeld T, Saxena AK.
    Eur J Pharmacol; 2013 Dec 05; 721(1-3):215-24. PubMed ID: 24075938
    [Abstract] [Full Text] [Related]

  • 20. Analogue-based design, synthesis and docking of non-steroidal anti-inflammatory agents. Part 2: methyl sulfanyl/methyl sulfonyl substituted 2,3-diaryl-2,3-dihydro-1H-quinazolin-4-ones.
    Manivannan E, Chaturvedi SC.
    Bioorg Med Chem; 2012 Dec 15; 20(24):7119-27. PubMed ID: 23146282
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.